Document Detail

The efficacy and safety of dilevalol in patients with chronic stable angina pectoris.
MedLine Citation:
PMID:  2574729     Owner:  NLM     Status:  MEDLINE    
This is the first reported large clinical trial of the antianginal and acute ischemic effectiveness and safety of dilevalol (the R, R-isomer of labetalol) in patients with chronic stable angina pectoris. This was a multicenter double blind fixed-dose parallel group placebo controlled trial. Patients with chronic stable angina and positive and reproducible exercise tests (+/- 20%) were included. If randomized, patients entered one of four fixed dose groups (twice a day placebo, 100 mgm, 200 mgm and 400 mgm bid for 2 weeks). Exercise testing was performed at 2 hours (peak) and 12 hours (trough) postdosing. This was followed by a 2-week once-a-day dosing regimen in which patients received the same total daily dose as the prior 2 weeks, with the full dose in the morning and a matched placebo in the evening. Exercise testing was performed at 2 hours (peak) and 24 hours (trough) postdosing. Anginal frequency and NTG consumption were significantly reduced, and equally so, by qd and bid regimens. The time of exercise to the onset of angina increased and the proportion of patients terminating exercise because of moderate angina decreased in a dose response fashion for both peak and trough tests and for both qd and bid regimens. There was also a dose related decrease in exercise induced ST segment depression and an increase in time to 1 mm ST depression. In 15 patients, 24-hour ambulatory monitoring also revealed a decrease in episodes of silent ischemia. No significant side effects related to the study drug occurred.(ABSTRACT TRUNCATED AT 250 WORDS)
S P Glasser; N Bittar; V Kinhal; W T Bennett; D K Koehn
Related Documents :
2575979 - Effect of partial agonist activity on the side effects of beta-blockade in patients wit...
3294189 - Antianginal efficacy of gallopamil in comparison to nifedipine.
10607869 - Nitric oxide generation, tachyphylaxis and cross-tachyphylaxis from nitrovasodilators i...
2782269 - Comparative study of the effect of nifedipine versus diltiazem on exercise performance,...
1084659 - Clinical and circulatory effects of oral isosorbide dinitrate in patients with angina d...
2518679 - The effect of nitroglycerin ointment on exercise-induced angina: a multicenter trial.
14531159 - Behavioral influences and physiological indices of ventilatory control in subjects with...
8088089 - Physiologic responses to training.
24796649 - Methacholine challenge is insufficient to exclude bronchial hyperresponsiveness in a sy...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of clinical pharmacology     Volume:  29     ISSN:  0091-2700     ISO Abbreviation:  J Clin Pharmacol     Publication Date:  1989 Nov 
Date Detail:
Created Date:  1990-01-31     Completed Date:  1990-01-31     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0366372     Medline TA:  J Clin Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  983-8     Citation Subset:  IM    
Division of Cardiology, University of South Florida College of Medicine, Tampa 33612.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / adverse effects,  therapeutic use*
Angina Pectoris / drug therapy*,  physiopathology
Chronic Disease
Coronary Disease / drug therapy,  physiopathology
Double-Blind Method
Labetalol / adverse effects,  therapeutic use*
Randomized Controlled Trials as Topic
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 36894-69-6/Labetalol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The efficacy and tolerability of nifedipine (NIF) and nisoldipine (NIS) both alone and combined with...
Next Document:  Pustular dermatosis of the scalp associated with autoimmune diseases.